Your gift to FACTMS through the Bob Sammons Clinical TMS Research Fund is a beacon of hope and transformation, empowering the next wave of innovation in mental health:

To honor Bob’s immense impact on the field of clinical TMS and his dedication, FACTMS is honoring his legacy by establishing the Bob Sammons fund for Clinical TMS research.  The fund will be used to provide researchers seed money for their TMS projects. Our goal is to present the first award during the CTMSS Annual Meeting in London (June 13 to 15, 2024). 

Igniting the Spark of Discovery

Your contribution nurtures aspiring young minds, providing the crucial grants that support pioneering clinical researchers dedicated to advancing TMS therapy. Together, we are fueling a future of limitless possibilities and groundbreaking treatments.

Opening doors to healing

We are committed to ensuring that TMS therapy reaches all corners of the community, offering free treatments to those facing financial barriers. Your generosity makes this vital support accessible, changing lives by making recovery possible for everyone, regardless of their financial situation.

Spreading the word, saving lives

With your help, we can amplify the message of TMS therapy’s life-changing benefits. Your support launches awareness campaigns that reach out to those in desperate need of a solution, spreading hope and potentially saving lives through increased access to this revolutionary treatment.

DONATE TO THE BOB SAMMON CLINICAL TMS RESEARCH FUND

DONATE TO THE BOB SAMMONS CLINICAL TMS RESEARCH FUND

Dr. Bob Sammons is a prominent figure in the field of Transcranial Magnetic Stimulation (TMS) therapy. He co-founded TMS Solutions in 2014 with the aim of expanding the availability of TMS for treating depression. Dr. Sammons is highly involved in the Clinical TMS Society (CTMSS), where he has served in various capacities, including the Outreach, Legal, Business and Ethics Committees, and as the Chairman of the Annual Meeting in 2023. He was also elected to the Executive Committee of CTMSS and has been recognized with the society’s first-ever Legacy Award for his contributions to the field.

As a veteran and a psychiatrist, Dr. Sammons has a particular interest in the potential of TMS to treat conditions such as PTSD, especially within the veteran community. His role extends beyond clinical practice as he is also engaged in research and education, serving as an adjunct research professor at Colorado Mesa University to help develop and publish research using TMS technology​ (Clinical TMS Society)​​ (TMS Solutions)​​ (TMS Solutions)​.